970*90
768
468
mobile

Sun pharma increases its stake in Ranbaxy Malaysia

Franchise India Bureau
Franchise India Bureau Oct 13 2017 - 1 min read
Sun pharma increases its stake in Ranbaxy Malaysia
Shares of Sun Pharmaceutical Industries on Thursday closed at Rs 539.40 per scrip on BSE

Major drug company Sun Pharmaceutical said it will increase share in its peripheral Ranbaxy Malaysia SDN BHD to 79.5 through purchasing of share.

Sun Pharma said in a filling to the BSE “One of the wholly owned subsidiaries of the company has agreed to increase its shareholding in Ranbaxy Malaysia Sdn Bhd by 8.3 per cent by way of purchase of around 6.66 lakh shares. Ranbaxy Malaysia SDN BHD is an alternate of Sun Pharma, and the company along with one of its wholly owned arms has 71.2% shares prior to the acquisition.

Shares of Sun Pharmaceutical Industries on Thursday closed at Rs 539.40 per scrip on BSE, up 2.59 per cent from its previous close.

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online